Viridian Capital Advisors

Viridian Capital Advisors is a leading corporate finance, M&A, advisory, and research firm specializing in the legal Cannabis/CBD and Psychedelics industries. Founded in 2014, the firm represents companies, investors, lenders, buyers, and sellers, offering comprehensive services to institutionalize clients before they go to market for capital or M&A. Their advisory practice focuses on building professional boards of directors, developing sophisticated financial models, conducting valuation analyses, and formulating exit strategies. Through their investment banking practice, Viridian raises capital and executes M&A transactions via their New York City-based broker-dealer, Bradley Woods & Co. Ltd. The firm is widely recognized as an industry leader in research and capital markets data through the Viridian Deal Tracker, a proprietary data service that monitors and analyzes investment, M&A activity, and capital markets trends in the Cannabis/CBD and Psychedelics industries. The Deal Tracker has become a trusted source for companies, investors, lenders, and sellers/acquirers to make informed capital allocation decisions. Viridian's team comprises former presidents, CEOs, and C-suite executives from major companies in the CPG, Big Brand, and Private Equity industries, including Diageo, Procter & Gamble, Anheuser Busch, Mars Wrigley, Dixie Brands, Pantheon Partners, and Conde Nast. Leveraging decades of high-level operating and transactional experience, they provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential. Their services include capital raising, mergers and acquisitions, valuation services, and industry research, all aimed at helping clients navigate the complexities of the cannabis and psychedelics markets to achieve superior results.

Companies operating in the legal Cannabis/CBD and Psychedelics industries seeking capital or strategic advisory services.